A comprehensive view of Otsuka Pharmaceutical Co. Ltd.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie's Rinvoq and Skyrizi top pharma ad spending in March, with Otsuka and Lundbeck's Rexulti climbing to third place; overall ad spend increases to US$188.0M from US$168.4M in February according to iSpot.TV data
Published: April 05, 2024 by FiercePharma
Novartis's drug Entresto receives approval for pediatric chronic heart failure indication in Japan, making it the first of its kind in the country; Novartis to collaborate with Otsuka to inform healthcare professionals about this new usage
Published: February 09, 2024 by Contify Life Science News
GlobalData expects psychedelic drug market to hit US$7.2B by 2029, reflecting 55% CAGR and driven by positive regulatory changes; by 2029, top drugs expected to be Atai Life Sciences/Otsuka Pharmaceutical's PCN-101, Cybin's CYB-003, Small Pharma's SPL-026
Published: September 26, 2023 by GlobalData Plc

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count